Clinical Trial Update: Pilot Study of Fosamax in Spinal Cord Injury [NA]

View source ↗

Summary

Pilot study evaluating alendronate (Fosamax) for osteoporosis in individuals with spinal cord injury; the trial was terminated and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)

Snippet

Sponsor: University of Rochester | Conditions: Spinal Cord Injury, Osteoporosis | NA | Status: TERMINATED | Results posted: 2013-09-16